Cohen NA - Search Results

1

Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative Colitis.

Cohen NA, Dalal SR, Choi D, Rubin DT. Cohen NA, et al. ACG Case Rep J. 2022 Jul 21;9(7):e00832. doi: 10.14309/crj.0000000000000832. eCollection 2022 Jul. ACG Case Rep J. 2022. PMID: 35919406 Free PMC article.

2

New targets in inflammatory bowel disease therapy: 2021.

Cohen NA, Rubin DT. Cohen NA, et al. Curr Opin Gastroenterol. 2021 Jul 1;37(4):357-363. doi: 10.1097/MOG.0000000000000740. Curr Opin Gastroenterol. 2021. PMID: 34059604 Free PMC article. Review.

3

Inclusion of Under-represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.

Cohen NA, Silfen A, Rubin DT. Cohen NA, et al. Gastroenterology. 2022 Jan;162(1):17-21. doi: 10.1053/j.gastro.2021.09.035. Epub 2021 Sep 22. Gastroenterology. 2022. PMID: 34562464 Free PMC article. No abstract available.

4

Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center.

Cohen NA, Choi D, Choden T, Cleveland NK, Cohen RD, Rubin DT. Cohen NA, et al. Among authors: cohen rd. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2407-2409.e2. doi: 10.1016/j.cgh.2022.03.035. Epub 2022 Apr 2. Clin Gastroenterol Hepatol. 2023. PMID: 35381385 Free PMC article.

5

Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis.

Mikolajczyk AE, Cohen NA, Watson S, Ackerman M, Goeppinger SR, Hart J, Turner JR, Rubin DT. Mikolajczyk AE, et al. Among authors: cohen na. Inflamm Bowel Dis. 2023 Feb 1;29(2):222-227. doi: 10.1093/ibd/izac070. Inflamm Bowel Dis. 2023. PMID: 35436339 Free PMC article. Review.

6

Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis.

Cohen NA, Zafer M, Setia N, Anderson MJ, Sakuraba A, Dalal S, Pekow J, Cohen RD, Rubin DT, Micic D. Cohen NA, et al. Among authors: cohen rd. Dig Dis Sci. 2023 Mar;68(3):897-901. doi: 10.1007/s10620-022-07607-4. Epub 2022 Jul 4. Dig Dis Sci. 2023. PMID: 35781654

7

Endoscopic Management of Colitis-Associated Neoplasia.

Cohen NA, Rubin DT. Cohen NA, et al. Gastrointest Endosc Clin N Am. 2022 Oct;32(4):863-873. doi: 10.1016/j.giec.2022.04.002. Epub 2022 Sep 7. Gastrointest Endosc Clin N Am. 2022. PMID: 36202521 Review.

8

Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes.

Cohen NA, Steinberg JM, Silfen A, Traboulsi C, Rodriguez TG, Singer JM, Patel S, Cohen RD, Dalal SR, Sakuraba A, Pekow J, Micic D, Rubin DT. Cohen NA, et al. Among authors: cohen rd. Dig Dis Sci. 2023 Apr;68(4):1464-1472. doi: 10.1007/s10620-022-07716-0. Epub 2022 Oct 15. Dig Dis Sci. 2023. PMID: 36242686 Review.

9

Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease.

Choden T, Cohen NA, Rubin DT. Choden T, et al. Among authors: cohen na. Gastroenterol Hepatol (N Y). 2022 May;18(5):265-271. Gastroenterol Hepatol (N Y). 2022. PMID: 36397756 Free PMC article.

10

Treat-to-target and sequencing therapies in Crohn's disease.

Garcia NM, Cohen NA, Rubin DT. Garcia NM, et al. Among authors: cohen na. United European Gastroenterol J. 2022 Dec;10(10):1121-1128. doi: 10.1002/ueg2.12336. Epub 2022 Dec 12. United European Gastroenterol J. 2022. PMID: 36507876 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters